TCL Archive Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction. April 21, 2006
TCL Archive SEER Data Show Under Age 55 Death Rates are Decreasing, Mixed Results In Various Categories December 12, 1986
TCL Archive Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction” September 11, 1998
TCL Archive L-PAM, Less Than Radical Surgery Results Holding Up, New Breast Cancer Studies Sought September 12, 1975
